Mesenchymal Stem Cells Markedly Suppress Inflammatory Bone Destruction in Rats with Adjuvant-induced Arthritis

Overview

Journal Lab Invest

Specialty Pathology

Date 2014 Jan 8

PMID 24395111

Citations 31

Authors

Toshio Takano

Yin-Ji Li

Akiko Kukita

Takayoshi Yamaza

Yasunori Ayukawa

Kanako Moriyama

Norihisa Uehara

Hisayuki Nomiyama

Kiyoshi Koyano

Toshio Kukita

Affiliations

Soon will be listed here.

Abstract

Mesenchymal stem cells (MSCs) have potential to differentiate into multiple cell lineages. Recently, it was shown that MSCs also have anti-inflammatory and immunomodulatory functions. In this report, we investigated the regulatory function of MSCs in the development of inflammatory bone destruction in rats with adjuvant-induced arthritis (AA rats). MSCs were isolated from rat bone marrow tissues, expanded in the presence of basic FGF, and intraperitoneally injected into AA rats. MSC administration significantly suppressed inflammatory parameters: swelling score, swelling width, and thickness of hind paw. Radiographic evaluation indicated that MSC significantly suppressed bone destruction. Histological analysis showed that administration of MSCs markedly suppressed osteoclastogenesis in AA rats. To further delineate their effects on osteoclastogenesis, MSCs were added to in vitro bone marrow cultures undergoing osteoclastogenesis. MSCs significantly suppressed osteoclastogenesis in this system. Chemokine receptor expression in MSCs was assessed by RT-PCR, and a chemotactic assay was performed using a transwell culture system. MSCs showed significant chemotaxis to MIP-1α (CCL3) and SDF-1α (CXCL12), chemokines preferentially expressed in the area of inflammatory bone destruction. Furthermore, MSCs expressed IL-10 and osteoprotegerin, cytokines that suppress osteoclastogenesis. These data suggest that recruitment of MSC to the area of bone destruction in AA rats could suppress inflammatory bone destruction and raise the possibility that MSCs may have potential for the treatment of inflammatory bone destruction in arthritis.

Citing Articles

iPSCs-derived iMSCs prevent osteoporotic bone loss and affect bone metabolites in ovariectomized mice.

Wang W, Wang Y, Bao S, He F, Li G, Yang G J Cell Mol Med. 2024; 28(22):e70200.

PMID: 39580790 PMC: 11586054. DOI: 10.1111/jcmm.70200.

Adipose-Derived Mesenchymal Stem Cells from Arthritis Patients: Differential Modulation of CD4⁺ T Cell Activation and Cytokine Production.

Oldak M, Kurowska W, Plebanczyk M, Janicka I, Radzikowska A, Skalska U Med Sci Monit. 2024; 30:e945273.

PMID: 39543859 PMC: 11575092. DOI: 10.12659/MSM.945273.

Engineering approaches to manipulate osteoclast behavior for bone regeneration.

Cheng X, Tian W, Yang J, Wang J, Zhang Y Mater Today Bio. 2024; 26:101043.

PMID: 38600918 PMC: 11004223. DOI: 10.1016/j.mtbio.2024.101043.

Adipose Tissue-Derived Mesenchymal Stem Cell Inhibits Osteoclast Differentiation through Tumor Necrosis Factor Stimulated Gene-6.

Lee K, Ko E, Park Y Tissue Eng Regen Med. 2024; 21(4):587-594.

PMID: 38451425 PMC: 11087411. DOI: 10.1007/s13770-023-00619-9.

and oxaloacetate in nucleus pulposus stromal cell somatic reprogramming and survival.

Lufkin L, Samanta A, Baker D, Lufkin S, Schulze J, Ellis B Front Mol Biosci. 2022; 9:1009402.

PMID: 36406265 PMC: 9671658. DOI: 10.3389/fmolb.2022.1009402.

References

Toh K, Kukita T, Wu Z, Kukita A, Sandra F, Tang Q . Possible involvement of MIP-1alpha in the recruitment of osteoclast progenitors to the distal tibia in rats with adjuvant-induced arthritis. Lab Invest. 2004; 84(9):1092-102. DOI: 10.1038/labinvest.3700132. View

Abe M, Hiura K, Wilde J, Moriyama K, Hashimoto T, Ozaki S . Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma. Blood. 2002; 100(6):2195-202. View

Broxmeyer H, Kim C, Cooper S, Hangoc G, Hromas R, Pelus L . Effects of CC, CXC, C, and CX3C chemokines on proliferation of myeloid progenitor cells, and insights into SDF-1-induced chemotaxis of progenitors. Ann N Y Acad Sci. 1999; 872:142-62; discussion 163. DOI: 10.1111/j.1749-6632.1999.tb08460.x. View

Lataillade J, Clay D, Dupuy C, Rigal S, Jasmin C, Bourin P . Chemokine SDF-1 enhances circulating CD34(+) cell proliferation in synergy with cytokines: possible role in progenitor survival. Blood. 2000; 95(3):756-68. View

Spaggiari G, Capobianco A, Abdelrazik H, Becchetti F, Mingari M, Moretta L . Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood. 2007; 111(3):1327-33. DOI: 10.1182/blood-2007-02-074997. View

Augello A, Tasso R, Negrini S, Amateis A, Indiveri F, Cancedda R . Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur J Immunol. 2005; 35(5):1482-90. DOI: 10.1002/eji.200425405. View

Lee K, Kim H, Kim J, Kim J, Kim K, Kim Y . Systemic transplantation of human adipose-derived stem cells stimulates bone repair by promoting osteoblast and osteoclast function. J Cell Mol Med. 2010; 15(10):2082-94. PMC: 4394219. DOI: 10.1111/j.1582-4934.2010.01230.x. View

Lee R, Seo M, Reger R, Spees J, Pulin A, Olson S . Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci U S A. 2006; 103(46):17438-43. PMC: 1634835. DOI: 10.1073/pnas.0608249103. View

Nagasawa T . Microenvironmental niches in the bone marrow required for B-cell development. Nat Rev Immunol. 2006; 6(2):107-16. DOI: 10.1038/nri1780. View

10.

Xu L, Kukita T, Kukita A, Otsuka T, Niho Y, Iijima T . Interleukin-10 selectively inhibits osteoclastogenesis by inhibiting differentiation of osteoclast progenitors into preosteoclast-like cells in rat bone marrow culture system. J Cell Physiol. 1995; 165(3):624-9. DOI: 10.1002/jcp.1041650321. View

11.

Chenu C, Pfeilschifter J, Mundy G, Roodman G . Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures. Proc Natl Acad Sci U S A. 1988; 85(15):5683-7. PMC: 281824. DOI: 10.1073/pnas.85.15.5683. View

12.

Kukita A, Kukita T, Ouchida M, Maeda H, Yatsuki H, Kohashi O . Osteoclast-derived zinc finger (OCZF) protein with POZ domain, a possible transcriptional repressor, is involved in osteoclastogenesis. Blood. 1999; 94(6):1987-97. View

13.

Fuller K, Lean J, Bayley K, Wani M, Chambers T . A role for TGFbeta(1) in osteoclast differentiation and survival. J Cell Sci. 2000; 113 ( Pt 13):2445-53. DOI: 10.1242/jcs.113.13.2445. View

14.

Simonet W, Lacey D, Dunstan C, Kelley M, Chang M, Luthy R . Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997; 89(2):309-19. DOI: 10.1016/s0092-8674(00)80209-3. View

15.

Nauta A, Fibbe W . Immunomodulatory properties of mesenchymal stromal cells. Blood. 2007; 110(10):3499-506. DOI: 10.1182/blood-2007-02-069716. View

16.

Huey D, Hu J, Athanasiou K . Unlike bone, cartilage regeneration remains elusive. Science. 2012; 338(6109):917-21. PMC: 4327988. DOI: 10.1126/science.1222454. View

17.

Kukita A, Kukita T, Hata K, Kurisu K, Kohashi O . Heat-treated osteoblastic cell (ROS17/2.8)-conditioned medium induces the formation of osteoclast-like cells. Bone Miner. 1993; 23(2):113-27. DOI: 10.1016/s0169-6009(08)80048-7. View

18.

Kukita T, Nomiyama H, Ohmoto Y, Kukita A, Shuto T, Hotokebuchi T . Macrophage inflammatory protein-1 alpha (LD78) expressed in human bone marrow: its role in regulation of hematopoiesis and osteoclast recruitment. Lab Invest. 1997; 76(3):399-406. View

19.

Kukita T, NAKAO J, Hamada F, Kukita A, Inai T, Kurisu K . Recombinant LD78 protein, a member of the small cytokine family, enhances osteoclast differentiation in rat bone marrow culture system. Bone Miner. 1992; 19(3):215-23. DOI: 10.1016/0169-6009(92)90871-a. View

20.

Hong M, Williams H, Jin C, Pike J . The inhibitory effect of interleukin-10 on mouse osteoclast formation involves novel tyrosine-phosphorylated proteins. J Bone Miner Res. 2000; 15(5):911-8. DOI: 10.1359/jbmr.2000.15.5.911. View